Literature DB >> 9006738

Immunotherapy of metastatic renal cell cancer.

S H Goey1, J Verweij, G Stoter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9006738     DOI： 10.1093/oxfordjournals.annonc.a010790

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

Review 1.  Specific immunotherapy in renal cancer: a systematic review.

Authors:  Armin Hirbod-Mobarakeh; Hesam Addin Gordan; Zahra Zahiri; Mohammad Mirshahvalad; Sima Hosseinverdi; Brian I Rini; Nima Rezaei
Journal:  Ther Adv Urol       Date:  2016-12-19

2.  A new method to estimate parameters of the growth model for metastatic tumours.

Authors:  Esmaeil Mehrara; Eva Forssell-Aronsson; Viktor Johanson; Lars Kölby; Ragnar Hultborn; Peter Bernhardt
Journal:  Theor Biol Med Model       Date:  2013-05-09       Impact factor: 2.432

3.  A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer.

Authors:  G C Jayson; M Middleton; S M Lee; L Ashcroft; N Thatcher
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.